Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

被引:1
作者
Liang, Leyi [1 ]
Shao, Taihang [1 ]
Li, Hao [1 ]
Zhao, Mingye [1 ]
Tang, Wenxi [1 ,2 ]
机构
[1] China Pharmaceut Univ, Ctr Pharmacoecon & Outcomes Res, Nanjing 211198, Peoples R China
[2] Pharmaceut Univ, Sch Int Pharmaceut Business, Dept Publ Affairs Management, Nanjing 211198, Peoples R China
基金
中国国家自然科学基金;
关键词
Prehypertension; Early management; Non-pharmacological intervention; Cost-effectiveness analysis; Budget impact analysis; China; BLOOD-PRESSURE; NUTRITION SURVEY; HYPERTENSION; HEALTH; RISK; ADULTS; PREVENTION; EXERCISE; DISEASE; PROFILE;
D O I
10.1186/s12889-023-16458-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundNon-pharmacological interventions (NPIs) could be considered in the early management of prehypertensive population. This study aimed to evaluate the potential cost-effectiveness of NPIs and the budget impact of implementing NPIs on prehypertensive population in China and provide evidence of chronic disease management innovation for decision-makers.MethodsFive NPIs including usual care, lifestyle, strengthen exercise, relaxation, and diet therapy were selected based on the practice of hypertension management in China. A nine-state Markov model was constructed to evaluate the lifetime costs and health outcomes of five NPIs and a non-intervention group from the perspective of Chinese healthcare system. The effectiveness of NPIs was obtained from a published study. Parameters including transition probabilities, costs and utilities were extracted or calculated from published literature and open-access databases. Sensitivity analyses were conducted to test the uncertainty of all parameters. The impact of duration of intervention was considered in scenario analyses. A budget impact analysis (BIA) was conducted to evaluate the total cost and the medical cost saving of a hypothetical nationwide implementation of potential cost-effective NPI in prehypertensive people. Management strategies including focusing on patients with specific ages or different CVE risk levels, and different duration of implementation were taken into consideration.ResultsStrengthen exercise was the most cost-effective intervention with a probability of 78.1% under the given WTP threshold. Our results were sensitive to the cost of interventions, and the utility of prehypertension and hypertension. The duration of implementation had limited impact on the results. BIA results showed that the program cost was hefty and far more than the medical cost saving with the course of simulation time. Applying management strategies which focused on individual characteristics could largely reduce the program cost despite it remained higher than medical cost saving.ConclusionsStrengthen exercise was a potential NPI that can be considered in priority for early management in prehypertensive population. Although early management can acquire medical cost saving, the related program cost can be quite hefty. Precise strategies which may help reduce the cost of early management should be taken into consideration in program design.
引用
收藏
页数:12
相关论文
共 59 条
[1]   Improving the delivery of brief interventions for heavy drinking in primary health care: outcome results of the Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster randomized factorial trial [J].
Anderson, Peter ;
Bendtsen, Preben ;
Spak, Fredrik ;
Reynolds, Jillian ;
Drummond, Colin ;
Segura, Lidia ;
Keurhorst, Myrna N. ;
Palacio-Vieira, Jorge ;
Wojnar, Marcin ;
Parkinson, Kathryn ;
Colom, Joan ;
Kloda, Karolina ;
Deluca, Paolo ;
Baena, Begona ;
Newbury-Birch, Dorothy ;
Wallace, Paul ;
Heinen, Maud ;
Wolstenholme, Amy ;
van Steenkiste, Ben ;
Mierzecki, Artur ;
Okulicz-Kozaryn, Katarzyna ;
Ronda, Gaby ;
Kaner, Eileen ;
Laurant, Miranda G. H. ;
Coulton, Simon ;
Gual, Toni .
ADDICTION, 2016, 111 (11) :1935-1945
[2]  
[Anonymous], 2020, NATL GUIDELINE HYPER, V48, P10, DOI DOI 10.3760/CMA.J.ISSN.0253-3758.2020.01.004
[3]  
Care. TNEPHSPOfMoHiPH disease
[4]  
NCfC care NCoHMiPH, 2021, Healthy children action improvement plan (2021-2025). National Health Commission of China, V3, P209
[5]   Three-year survival after first-ever ischemic stroke is predicted by initial stroke severity: A hospital-based study [J].
Chang, Ku-Chou ;
Lee, Hsuei-Chen ;
Tseng, Mei-Chiun ;
Huang, Yu-Ching .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2010, 112 (04) :296-301
[6]  
Chen C, 2012, RES PERFECTING COST
[7]   Predictors of 1-year outcomes in the Taiwan Acute Coronary Syndrome Full Spectrum Registry [J].
Chiang, Fu-Tien ;
Shyu, Kou-Gi ;
Wu, Chiung-Jen ;
Mar, Guang-Yuan ;
Hou, Charles Jia-Yin ;
Li, Ai-Hsien ;
Wen, Ming-Shien ;
Lai, Wen-Ter ;
Lin, Shing-Jong ;
Kuo, Chi-Tai ;
Kuo, Chieh ;
Li, Yi-Heng ;
Hwang, Juey-Jen .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (11) :794-802
[8]   Prediction models for the risk of new-onset hypertension in ethnic Chinese in Taiwan [J].
Chien, K-L ;
Hsu, H-C ;
Su, T-C ;
Chang, W-T ;
Sung, F-C ;
Chen, M-F ;
Lee, Y-T .
JOURNAL OF HUMAN HYPERTENSION, 2011, 25 (05) :294-303
[9]   Constructing the Prediction Model for the Risk of Stroke in a Chinese Population Report From a Cohort Study in Taiwan [J].
Chien, Kuo-Liong ;
Su, Ta-Chen ;
Hsu, Hsiu-Ching ;
Chang, Wei-Tien ;
Chen, Pei-Chun ;
Sung, Fung-Chang ;
Chen, Ming-Fong ;
Lee, Yuan-Teh .
STROKE, 2010, 41 (09) :1858-1864
[10]   The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia [J].
Conti, Rena M. ;
Padula, William, V ;
Becker, Russell, V ;
Salamone, Salvatore .
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (08) :1077-1085